Navigation Links
Daniel Sontupe, SVP, Director of Market Access, at The CementBloc, to Present on Uncovering the Value in a Patient Support Program at CBI Summit
Date:6/18/2012

NEW YORK, June 18, 2012 /PRNewswire/ -- Daniel Sontupe, SVP, Director Market Access, at The CementBloc, will be presenting his expertise on the value of patient support programs at CBI's 5th Bio/Pharmaceutical Summit on Managed Care Marketing in Philadelphia, Pennsylvania on June 20, 2012. 

The conference is a two-day symposium designed for senior-level pharmaceutical and biotechnology professionals seeking to understand which payers are most valuable and what messages and value propositions drive decision makers in order to maximize market access. Mr. Sontupe will be presenting the basics of analyzing and developing a multifaceted patient support program in his talk entitled, "Uncovering the Value in a Patient Support Program." Mr. Sontupe will bring to the symposium his unique expertise in determining what needs to be developed to create a successful patient support program that eases the clutter in the prescriber's office.

"The pharmaceutical reimbursement and market access challenge continues to expand for pharmaceutical marketers and today spreads well beyond health plans and employers," says Mr. Sontupe. "As the Supreme Court debates the validity of the Affordable Care Act, we need to develop varied ways to help healthcare professionals navigate this ever-changing space and help ensure patients access to the appropriate therapies."

At The CementBloc, Mr. Sontupe oversees the market access team, responsible for helping craft both payer-facing and HCP-facing strategies and tactics to tackle health plan coverage and product reimbursement issues. Dan has spent nearly 20 years navigating the managed markets, beginning his career as an analyst and manager at Medco (now part of Express Scripts) and as a product manager and director at Sanofi-Aventis and Watson Pharmaceuticals, respectively. Dan and his team are constantly developing new ways to communicate a drug's value to the payer while at the same time supporting the HCP's need to be knowledgeable and resourced to negotiate the process on behalf of their patients for delivery of appropriate treatments and associated reimbursement support.

About The CementBloc: The CementBloc is a leading multichannel healthwellness creative agency based in New York. Founded in 2000 by Susan Miller Viray and Rico Viray, The CementBloc is also a founding member of Indigenus, an independent global network of entrepreneurial healthcare creative agencies.

http://www.thecementbloc.com/


'/>"/>
SOURCE The CementBloc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Okuma America Chooses The Daniel Group To Provide Customer Service Research
2. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
3. Angeion Selects Hendrik Struik for Board of Directors
4. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
5. WAISMANN METHOD® Director Encourages Public to Participate in National Take-Back Day
6. SCOLR Pharma Welcomes Clem Calabrese as Director of Field Sales
7. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
8. WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day
9. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
10. Allscripts Adds Two Independent Directors to Board
11. Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... DIEGO, Feb. 4, 2016  Aethlon Medical, Inc. ... affinity biofiltration devices to treat life-threatening diseases, today ... 2016 ended December 31, 2015. ... objectives set forth in our last quarterly call, ... reinforce our long-term objective to establish the Aethlon ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
Breaking Medicine News(10 mins):